Acral with melanoma: A review of 185 patients identification of prognostic variables
The DOI matches its Crossref record.
Abstract
One hundred eight‐five patients with acral melanoma treated since 1972 were reviewed. These included 53 subungual lesions, 123 plantar lesions, and 9 palmar lesions. Eighty percent presented with stage I disease. Mean age was 57 years. Males outnumbered females 1.1:1. Seventeen percent (17%) were blacks. Actuarial 10‐year survival was 58% for stage I patients and 35% for stage II patients. Univariate Cox regression analyses identified 5 prognostic variables affecting survival: stage at diagnosis (P< 0.00l), race (P< 0.00l), ulceration (P=0.012), Clark's level (P=0.014), and thickness of the primary lesion (P=0.013). Factors unrelated to survival included sex of the patient, site (volar vs. subungual), histology, and treatment with amputation. Multivariate analysis for patients with stage I lesions identified race (P=0.00l) and ulceration (P=0.018) as significant variables, with thickness approaching significance (P=0.094). In an additional series of 71 patients with melanomas arising from extremity sites near the junction of glabrous and non‐glabrous skin, survival was significantly poorer for those arising from glabrous skin (P=0.024), and reflects a higher incidence of metastatic disease at diagnosis. Specific active immunotherapy was the principal adjuvant used for these patients, and survival was comparable to that reported with regional perfusion therapy. Acral melanoma a) has a strong racial predilection, b) carries a grave prognosis, and c) arises from glabrous skin. It is a clinical entity distinct from other extremity melanomas. Surgical management with either wide excision or amputation is appropriate for the primary lesion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Balch, C. M., Buzaid, A. C., Soong, S.-J., Atkins, M. B., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3635 · Cited by 2,636
Gloster, H. M., & Neal, K. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.08.063 · Cited by 668
Acral Lentiginous Melanoma: Incidence and Survival Patterns in the United States, 1986-2005
Bradford, P. T., Goldstein, A. M., McMaster, M. L., & Tucker, M. A. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2008.609 · Cited by 599
Markovic, S. N., Erickson, L. A., Rao, R. D., McWilliams, R. R., Kottschade, L. A., Creagan, E. T., Weenig, R. H., Hand, J. L., Pittelkow, M. R., Pockaj, B. A., et al. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61033-1 · Cited by 503
Acral lentiginous melanoma: a clinicoprognostic study of 126 cases: Prognosis of ALM
Phan, A., Touzet, S., Dalle, S., Ronger-Savlé, S., Balme, B., & Thomas, L. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07368.x · Cited by 285
Kuchelmeister, C., Schaumburg-Lever, G., & Garbe, C. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03651.x · Cited by 260
Robinson, J. K., Joshi, K. M., Ortiz, S., & Kundu, R. V. (2011) · Psycho-Oncology · doi:10.1002/pon.1736 · Cited by 80
Metadata
- Authors
- Slingluff, C. L., Vollmer, R., & Seigler, H. F.
- Venue
- Journal of Surgical Oncology
- Publisher
- Wiley
- Published
- 1990-10
- Volume
- 45
- Issue
- 2
- Pages
- 91-98
- ISSN
- 0022-4790 (ISSN-L)
- 1096-9098
- OpenAlex
- W2068424910
- Cited by
- 126
- References
- 0
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.